Disc Medicine (IRON) Research & Development (2020 - 2026)

Disc Medicine (IRON) has 7 years of Research & Development data on file, last reported at $45.9 million in Q1 2026.

• On a quarterly basis, Research & Development rose 65.34% year-over-year to $45.9 million in Q1 2026; TTM through Mar 2026 was $188.8 million, a 87.41% increase from a year earlier, with the FY2025 full-year figure at $170.6 million, up 76.52% from the prior year.
• Research & Development for Q1 2026 stood at $45.9 million, down from $46.2 million in the prior quarter.
• Over the last five years, Research & Development for IRON reached as high as $50.3 million in Q3 2025 and fell as low as $7.7 million in Q2 2022.
• Historically, Research & Development has averaged $24.5 million across 5 years, with a median of $23.5 million in 2024.
• On a YoY basis, Research & Development climbed as much as 191.78% in 2022 and fell as far as 41.39% in 2022.
• Year by year, Research & Development stood at $10.0 million in 2022, then surged by 125.29% to $22.6 million in 2023, then increased by 9.89% to $24.8 million in 2024, then jumped by 86.41% to $46.2 million in 2025, then retreated by 0.69% to $45.9 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $45.9 million in Q1 2026, $46.2 million in Q4 2025, and $50.3 million in Q3 2025.